Monday, Dec 18, 2017
engineered enzymes for better healthcare

El innovador producto de diagnóstico de Enzolve Technologies, el NeoScreenPak, consta de una serie de pruebas para el cribado neonatal de 7 de los 11 trastornos hereditarios más comúnmente diagnosticados. Estas pruebas se llevarán a cabo en una sencilla plataforma única, que puede sustituir a un gran número de tecnologías diversas, y generalmente bastante complejas, utilizadas actualmente a escala internacional en el diagnóstico de dichos trastornos.

Más información

 

 

 

 

 

 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...